← Leaderboards
Wolfgang Michael Korn
University Of California San Francisco
$7,457,664
Attributed
$7,457,664
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$7,457,664 · 4
By mechanism
U54$5,284,413 · 2
R01$2,173,251 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Kevin M Shannon$44,683,939
- Gordon B. Mills$27,749,983
- Joan M O'Brien$20,603,895
- Daniel J Lerner$801,753
- Su Guo$23,174,473
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularPathway InteractionsMediatingInhibitor/AntagonistBaseSignal TransductionCell Cycle ArrestGenesMeksComputer SimulationResearch StudyValidationCancer Cell LineMeasurementMathematical ModelCellsApoptosisPredispositionCancer CellMek InhibitionProteinsEngineeringCluster AnalysisCell Cycle
Grant awards (19)
Modeling response to MAPK Inhibitors$572,859
U54 · FY2014 · CA · contact PI
Modeling response to MAPK Inhibitors$507,449
U54 · FY2013 · CA · contact PI
Modeling response to MAPK Inhibitors$542,126
U54 · FY2012 · CA · contact PI
Modeling response to MAPK Inhibitors$596,448
U54 · FY2011 · CA · contact PI
Modeling response to MAPK Inhibitors$628,772
U54 · FY2010 · CA · contact PI
Experimentally Validated Mathematical Modeling of Oncolytic Virus Infection$211,977
R01 · FY2009 · CA · contact PI
CELLULAR AND MOLECULAR RESPONSES TO TARGETED THERAPY$638,904
U54 · FY2008 · CA · contact PI
Experimentally Validated Mathematical Modeling of Oncolytic Virus Infection$211,977
R01 · FY2008 · CA · contact PI
CELLULAR AND MOLECULAR RESPONSES TO TARGETED THERAPY$691,667
U54 · FY2007 · CA · contact PI
The Adenovirus Receptor CAR in Epithelial Malignancies$255,696
R01 · FY2007 · CA · contact PI
Experimentally Validated Mathematical Modeling of Oncolytic Virus Infection$211,621
R01 · FY2007 · CA · contact PI
CELLULAR AND MOLECULAR RESPONSES TO TARGETED THERAPY$380,026
U54 · FY2006 · CA · contact PI
The Adenovirus Receptor CAR in Epithelial Malignancies$263,333
R01 · FY2006 · CA · contact PI
Experimentally Validated Mathematical Modeling of Oncolytic Virus Infection$217,503
R01 · FY2006 · CA · contact PI
CELLULAR AND MOLECULAR RESPONSES TO TARGETED THERAPY$369,734
U54 · FY2005 · CA
The Adenovirus Receptor CAR in Epithelial Malignancies$269,670
R01 · FY2005 · CA
CELLULAR AND MOLECULAR RESPONSES TO TARGETED THERAPY$356,428
U54 · FY2004 · CA
The Adenovirus Receptor CAR in Epithelial Malignancies$269,670
R01 · FY2004 · CA
Adenovirus Receptor CAR in Epithelial Malignancies$261,804
R01 · FY2003 · CA